These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Angiotensin II: a new approach for refractory shock management? Kimmoun A; Levy B Crit Care; 2014 Dec; 18(6):694. PubMed ID: 25645552 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II in septic shock. Jadhav AP; Sadaka FG Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784 [TBL] [Abstract][Full Text] [Related]
7. Noradrenaline as a vasoactive agent in septic shock. Tordoff SG; Thompson JL; Williams AW Intensive Care Med; 2000 May; 26(5):648. PubMed ID: 10923747 [No Abstract] [Full Text] [Related]
8. Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient. Ryding J; Heslet L; Hartvig T; Jønsson V Chest; 1995 Jan; 107(1):201-3. PubMed ID: 7813278 [TBL] [Abstract][Full Text] [Related]
9. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia. Bui AD; Helgeson SA; Guru PK; Sanghavi DK BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32595128 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock. Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560 [TBL] [Abstract][Full Text] [Related]
14. Terlipressin bolus induces systemic vasoconstriction in septic shock. Peters MJ; Booth RA; Petros AJ Pediatr Crit Care Med; 2004 Mar; 5(2):112-5. PubMed ID: 14987338 [TBL] [Abstract][Full Text] [Related]
15. Vasopressin infusion in children with catecholamine-resistant septic shock. Vasudevan A; Lodha R; Kabra SK Acta Paediatr; 2005 Mar; 94(3):380-3. PubMed ID: 16028663 [TBL] [Abstract][Full Text] [Related]
16. THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW). Rurua M; Machavariani K; Sanikidze T; Shoshiashvili V; Pachkoria E; Ratiani L Georgian Med News; 2022 Feb; (323):157-161. PubMed ID: 35271489 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*. Asfar P; Chawla L; Lerolle N; Radermacher P Crit Care Med; 2014 Aug; 42(8):1961-3. PubMed ID: 25029144 [No Abstract] [Full Text] [Related]
18. Vasodilatory shock in the ICU and the role of angiotensin II. Wakefield BJ; Sacha GL; Khanna AK Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879 [TBL] [Abstract][Full Text] [Related]
19. Vasopressor therapy in critically ill patients with shock. Russell JA Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies. Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]